We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Structural Biology Helps Drive Coronavirus Vaccine Development

News   Mar 03, 2020 | Original story from the NIH Director’s Blog

 
Structural Biology Helps Drive Coronavirus Vaccine Development

This scanning electron microscope image shows SARS-CoV-2 (magenta) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S. Credit: NIAID-RML

 
 
Advertisement
 

RELATED ARTICLES

New Immune Cell on the Block During Viral Lung Infections

News

Scientists have identified a novel group of immune cells in the lungs that are associated with the control of inflammation during viral infections, like influenza or possibly coronavirus. This discovery may help to advance the development of therapeutics to treat inflammation-related lung conditions such as bronchitis, influenza and potentially even COVID-19.

READ MORE

Progress Made Towards a Simple, Low-cost CRISPR-based SARS-CoV-2 Diagnostic

News

Researchers at the University of Connecticut have been working to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including the novel coronavirus (SARS-CoV-2).

READ MORE

Histone Deacetylase May Be a Novel Therapeutic Strategy for Lung Cancer

News

In continued efforts to reduce the mortality rate of non-small cell lung cancer (NSCLC), researchers have demonstrated how targeting the histone deacetylase HDAC11 may be a novel therapeutic strategy for NSCLC.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE